COMMUNIQUÉS West-GlobeNewswire
-
GeneCentric Launches ExpressCT Rewind™ to Unlock Gene Expression Insights from Existing Liquid Biopsy DNA Sequencing
08/07/2026 -
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
08/07/2026 -
UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
08/07/2026 -
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
08/07/2026 -
Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
08/07/2026 -
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
08/07/2026 -
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
08/07/2026 -
ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)
08/07/2026 -
SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform
08/07/2026 -
American Physical Therapy Association and Inteleos Activate Partnership with First Joint Educational Program for Musculoskeletal Ultrasound Imaging Standards and Certification
08/07/2026 -
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
08/07/2026 -
Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
08/07/2026 -
NOMAD Increases Voyager Fleet Energy Storage by up to 56%, Bringing Eagle and Falcon to 2.025 MWh
08/07/2026 -
Tekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to Ohio
08/07/2026 -
SRX Global Declares One-Time Cash Dividend
08/07/2026 -
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
08/07/2026 -
Families Report Positive Outcomes From Fully Virtual, BCBA-Delivered, Focused Autism Support Program
08/07/2026 -
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
08/07/2026 -
Polomar Health Services Strengthens Board Leadership to Support Standalone Growth Strategy
08/07/2026
Pages